Neuropharmacological actions of Panchagavya formulation containing Emblica officinalis Gaerth and Glycyrrhiza glabra Linn in mice

Indian Journal of Experimental Biology

Volumn 42, Issue 5, 2004, Pages 499-503

  Achliya, Girish S ^a   Wadodkar, Sudhir G ^a   Dorle, Avinash K ^a  

^a RTM NAGPUR UNIVERSITY   (India)

Author keywords

Anticonvulsants; CNS; Emblica officinalis; Glycyrrhiza glabra; Neuropharmacological activity; Panchagavya; Sedative

Indexed keywords

BIPED LOCOMOTION; BRAIN; DISEASES; ELECTROPHYSIOLOGY; NEUROLOGY; PATIENT TREATMENT;

ELECTROSHOCK-INDUCED SEIZURES; SPONTANEOUS LOCOMOTOR ACTIVITY;

DRUG PRODUCTS;

AMPHETAMINE DERIVATIVE; ANTICONVULSIVE AGENT; HYPNOTIC SEDATIVE AGENT; PENTETRAZOLE; PENTOBARBITAL;

ANIMAL; ARTICLE; CATTLE; DOSE RESPONSE; DRUG EFFECT; ELECTRIC SHOCK; EMBLICA OFFICINALIS; FAT INTAKE; GLYCYRRHIZA; METABOLISM; MOTOR ACTIVITY; MOUSE; SLEEP; TIME;

AMPHETAMINES; ANIMALS; ANTICONVULSANTS; CATTLE; DIETARY FATS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROSHOCK; GLYCYRRHIZA; HYPNOTICS AND SEDATIVES; MICE; MOTOR ACTIVITY; PENTOBARBITAL; PENTYLENETETRAZOLE; PHYLLANTHUS EMBLICA; SLEEP; TIME FACTORS;

ANIMALIA; BOS TAURUS; GLYCYRRHIZA; GLYCYRRHIZA GLABRA; PHYLLANTHUS EMBLICA;

EID: 2442485801     PISSN: 00195189     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Calixto J B, Efficacy, safety, quality control, marketing and regulatory guidelines for herbal medicines (Phytotherapeutic agents). Braz J Med Biol Res, 33 (2000) 179.
2. Achliya G S, Kotagale N R, Wadodkar S G & Dorle A K, Hepatoprotective activity of panchagavya ghrita against carbon tetrachloride induced hepatotoxicity in rats. Indian J Pharmacol, 35 (2003) 308.
3. Khanuja S P S, Pharmaceutical composition containing cow urine distillate and an antibiotic. US Patent, 6410059, (2002).
4. Fulzele S V, Satturwar P M, Joshi S B & Dorle A K, Study of immunomodulatory activity of Haridradi ghrita in rats, Indian J Pharmacol, 35 (2003), 51.
5. Fulzele S V, Bhurchandi P M, Kanoje V M, Joshi S B & Dorle A K, Immunostimulant activity of Ashtamangal ghrita in rats, Indian J Pharmacol, 34 (2002) 194.
6. Fulzele S V, Satturwar P M, Joshi S B & Dorle A K, Studies on anti-inflammatory a ctivity of a polyherbal formulation - Jatyadi ghrita, Indian Drugs, 39 (2002) 42.
7. Tripathi B, Caraka Samhita, III edition (Chaukhamba Surbharati Prakashan Varanasi), 1994, 413.
8. Sai Ram M, Neetu D, Yogesh B, Anju B, Dipti P, Pauline J, Sharma S K, Sarada S K, Ilavazhagan G, Kumar D & Selvamurthy W, Cytoprotective and immunomodulating properties of Amla (Emblica officinalis) on lymphocytes: An in vitro study, J Ethnopharmacol, 81 (2002) 5.
9. Bhattacharya A, Ghoshal S & Bhattacharya S K, Antioxidant activity of tannoid principles of Emblica officinalis (amla) in chronic stress induced changes in rat brain, Indian J Exp Biol, 38 (2000) 877.
10. Al-Rehaily, A J, Al-Howiriny T A, Al-shaibani M O & Rafatullah S, Gastroprotective effects of 'Amla' Emblica officinalis on in vivo test models in rats, Phytomedicine, 9 (2002) 515.
11. Augusti K T, Arathy S L, Asha R, Ramakrishnan J, Zaira J, Lekha V, Smitha S & Vijayasree V M, A comparative study on the beneficial effects of garlic (Allium sativum L.), amla (Emblica officinalis G.) and onion (Allium cepa L.) on the hyperlipidermia induced by butter fat and beef fat in rats, Indian J Exp Biol, 39 (2001) 760.
12. Sai Ram K, Rao Ch. V, Babu M D, Kumar K V, Agrawal V K & Goel R K, Antiulcerogenic effect of inethanolic extract of Emblica officinalis: An experimental study, J Ethnopharmacol, 82 (2002) 1.
13. Biondi D M, Rocco C & Roberto G. New dihydrostilbene derivatives from the leaves of Glycyrrhiza glabra and evaluation of their antioxidant activity, J Natural Products, 66 (2003) 477.
14. Khayyal M T, el-Ghazaly M A, Kenawy S A, Seif-el-Nasr M, Mabran L G, Kafafi Y A & Okpanyi S N, Antiulcerogenic effect of some gastrointestinally acting plant extracts and their combination, Arzneimittelforschung, 51 (2001) 545.
15. Ambawade S D, Kasture V S & Kasture S B, Anticonvulsant activity of roots and rhizomes of Glycyrrhiza glabra. Indian J Pharmacol, 34 (2002) 251.
16. Thyagarajan S, Jayaram S, Gopalakrishnan V, Hari R, Jeyakumar P & Sripathi M, Herbal medicines for liver disorders in India, J Gastroenterol and Hepatol, 3 (2002), S370.
17. Irwin S, Comprehensive observational assessment: 1a A systematic quantitative procedure for assessing the behavioural and physiological state of mouse, Psychopharmacology, 13 (1968) 222.
18. Swinyard E A, Brown W C & Goodman L S, Comparative assay of antiepileptic drugs in mice and rats, J Pharmacol Exp Ther, 106 (1952) 319.
19. Parmar S S, Joshi D C, Ali B & Carnatzer W E, Anticonvulsant activity and inhibition of respiration in rat brain homogenates by substituted oxadiazoles, J Pharm Sci, 63 (1974) 872.
20. Contreras C M, Chacon L & Enriquez R G, Anticonvulsant properties of Ipomea stans, Phytomedicine, 3 (1996) 41.
21. Dunham M W & Miya T S, A note on a simple apparatus for detecting neurological deficit in rat and mice, J Am Pharm Assoc Sci , 46 (1957) 208.
22. Leewanich P, Tohda M, Matsumoto K, Subhadhirsakul S, Tyama H & Watanabe H, Behavioural studies on alkaloids extracted from the leaves of Hunteria zeylanica, Biol Pharm Bull, 19 (1996) 394.
23. Kaul P N & Kulkarni S K, New drug metabolism inhibitor of marine origin, J Pharm Sci, 67 (1978) 1293.
24. N'Gouemo P, Nquemby-bina C & Baldy-Moulinier M, Some neuropharmacological effects of an ethanol extracts of Maprounea africana in rodents, J Ethnopharmacol, 43 (1994) 161.
25. Perez R M G, Perez J A L, Garcia L M D & Sossa H M, Neuropharmacological activity of Solanum nigrum fruit, J Pharmacol, 62 (1998) 43.
26. Kasture V S, Chopde C T & Deshmukh V K, Anticonvulsive activity of Albizzia lebbeck, Hibiscus rosa sinesis and Butea monosperma in experimental animals, J Ethnopharmacol, 71 (2000) 65.
27. Capasso A, De Feo V, DeSimone F & Sorrentino L, Pharmacological effect of the aqueous extract from Valeriana adscendeus, Phytother Res, 10 (1996) 309.
28. Rogawski M A & Porter R J, Antiepileptic drugs and pharmacological mechanisms and clinical efficacy with consideration of promising developmental stage compounds, Pharmacol Rev, 42 (1995) 223.